老年亚急性髂股深静脉血栓:腔内治疗与单纯抗凝的2年结局比较
该回顾性研究纳入121例老年亚急性髂股深静脉血栓患者,比较腔内治疗联合抗凝与单纯抗凝的安全性和2年结局。两组出血事件等安全性无显著差异,血栓后综合征总体发生率无差异,但腔内治疗组严重血栓后综合征发生率更低且静脉疾病特异性生活质量改善更明显。
要点
- 老年亚急性髂股深静脉血栓患者中,腔内治疗联合抗凝与单纯抗凝的安全性相当。
- 腔内治疗可降低严重血栓后综合征的发生率,并改善静脉疾病特异性生活质量。
- 两组血栓后综合征总体发生率无显著差异。
核心结论
- 在老年亚急性髂股深静脉血栓患者中,腔内治疗联合抗凝的安全性与单纯抗凝相似,且能显著降低严重血栓后综合征发生率并改善静脉疾病特异性生活质量。
研究设计与样本
- 回顾性分析2021年1月至2023年1月连续住院的老年亚急性髂股深静脉血栓患者临床数据,按治疗方式分为腔内治疗组(53例)和单纯抗凝组(68例),共121例。
主要发现
- 两组任何出血事件、导管相关感染、急性肾功能不全或症状性肺栓塞均无显著差异。
- 2年随访期间,血栓后综合征(定义为Villalta评分≥5或溃疡)发生率无显著差异(45.3% vs. 55.9%;P = 0.275)。
- 严重血栓后综合征(Villalta评分≥15或溃疡)发生率腔内治疗组显著低于单纯抗凝组(17.0% vs. 35.3%;P = 0.039)。
- 静脉临床严重程度评分≥8的发生率腔内治疗组显著低于单纯抗凝组(13.2% vs. 33.8%;P = 0.011)。
- CIVIQ评分两组差异有统计学意义[(62.57 ± 12.03) vs. (56.79 ± 10.70);P = 0.006]。
临床怎么用
- 对于老年亚急性髂股深静脉血栓患者,在评估出血风险后可考虑腔内治疗联合抗凝,以降低严重血栓后综合征风险并改善生活质量。
局限性
- 本研究为单中心回顾性分析,样本量有限,结果需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To study the safety outcomes and the subsequent occurrence of post-thrombotic syndrome (PTS) after endovascular therapy (ET) combined with anticoagulation versus anticoagulation alone (AC) in treatment of subacute iliofemoral deep vein thrombosis (IFDVT) in elderly patients. METHODS: A retrospective analysis of the clinical data of consecutive elderly patients hospitalized for subacute IFDVT between January 2021 and January 2023 was conducted. According to the treatment, patients were divided into the ET group and the AC group. The safety outcomes, the occurrence of PTS, and differences in Chronic Venous Insufficiency Questionnaire (CIVIQ) score within 2 years were compared between the groups. RESULTS: The data of 121 patients were analyzed, among which 53 were in the ET group and 68 in the AC group. No significant differences were observed in any bleeding events, catheter-related infection, acute renal insufficiency, or symptomatic pulmonary embolism between groups. During the 2-year follow-up, there was no significant difference in the incidence of PTS (defined as a Villalta score ≥ 5 or ulcer: 45.3% vs. 55.9%; P = 0.275). However, the severity of PTS differed significantly between groups (Villalta score ≥ 15 or ulcer: 17.0% vs. 35.3%; P = 0.039; Venous Clinical Severity Score ≥ 8: 13.2% vs. 33.8%; P = 0.011). In addition, the CIVIQ score showed a statistically significant difference [(62.57 ± 12.03) vs. (56.79 ± 10.70); P = 0.006]. CONCLUSION: In elderly patients with subacute IFDVT, ET demonstrated similar safety outcomes to AC. Moreover, ET significantly reduced the incidence of severe PTS and led to greater improvement in venous disease-specific quality of life.
引用
- Hu D, Huang L, Lu Y, et al. Comparison of Endovascular Therapy Versus Anticoagulation Alone for the Treatment of Subacute Iliofemoral Deep Vein Thrombosis in Elderly Patients: Measures of 2-Year Clinical Outcome and Quality of Life. Ann Vasc Surg. 2025. PMID: 41067524. doi:10.1016/j.avsg.2025.09.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。